— Know what they know.
/
Not Investment Advice

MDGL NASDAQ

Madrigal Pharmaceuticals, Inc.
1W: -5.8% 1M: -14.8% 3M: -19.5% YTD: -25.9% 1Y: +4.5% 3Y: +234.8% 5Y: +446.5%
$440.33
+2.59 (+0.59%)
 
Weekly Expected Move ±4.1%
$399 $416 $434 $452 $470
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 27 · $10.2B mcap · 22M float · 1.51% daily turnover · Short 47% of daily vol
Credit Risk of going bust: lower than 79% of companies Debt: 3.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.39 (down 99.7%), Madrigal Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $347.8M against a stock market value of $10.17B.
Distance to default 9.47 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $171.4M (short-term plus half of long-term), stock volatility 43.5%; Altman Z'' -2.35. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
43.0 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -778.9%  ·  5Y Avg: -367.7%
Cost Advantage ★
59
Intangibles
26
Switching Cost
53
Network Effect
47
Scale
29
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. MDGL shows a Weak competitive edge (43.0/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. Negative ROIC of -778.9% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$605
Low
$752
Avg Target
$962
High
Based on 4 analysts since Jul 30, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 22Hold: 2Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$718.60
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-14 UBS Ashwani Verma $900 $735 -165 +62.6% $452.12
2026-09-24 Goldman Sachs — $571 $704 +133 +37.2% $513.02
2026-08-04 Wolfe Research — $579 $605 +26 +25.5% $482.00
2026-07-31 Barclays — $964 $962 -2 +95.1% $493.11
2026-07-29 Canaccord Genuity — $578 $587 +9 +8.9% $538.80
2026-07-27 Wells Fargo — $130 $685 +555 +25.8% $544.51
2026-06-11 Morgan Stanley — Initiated $542 — +15.0% $471.32
2026-05-13 Truist Financial — $640 $709 +69 +38.1% $513.30
2026-05-07 Evercore ISI — $405 $649 +244 +20.2% $539.73
2026-05-07 Canaccord Genuity — $420 $578 +158 +7.1% $539.73
2026-01-27 Barclays — Initiated $964 — +92.6% $500.39
2026-01-14 Goldman Sachs Andrea Tan $375 $571 +196 +15.6% $493.90
2026-01-06 Wolfe Research Andy Chen Initiated $579 — -1.6% $588.40
2025-12-19 Piper Sandler Yasmeen Rahimi $540 $900 +360 +52.9% $588.81
2025-12-19 UBS — $410 $900 +490 +65.3% $544.41
2025-11-21 H.C. Wainwright — $390 $620 +230 +11.0% $558.61
2025-11-20 Oppenheimer Jay Olson $590 $650 +60 +14.4% $568.01
2025-11-19 Truist Financial — $580 $640 +60 +15.2% $555.60
2025-11-05 JMP Securities — $397 $527 +130 +18.5% $444.64
2025-10-15 Piper Sandler — $336 $540 +204 +23.5% $437.10
2025-10-14 Truist Financial — Initiated $580 — +32.7% $437.10
2025-10-10 Oppenheimer Jay Olson $250 $590 +340 +37.8% $428.30
2025-05-02 Canaccord Genuity Edward Nash Initiated $420 — +33.1% $315.48
2024-05-29 Piper Sandler Yasmeen Rahimi Initiated $336 — +51.5% $221.75
2024-05-09 H.C. Wainwright Ed Acre $425 $390 -35 +87.5% $208.04
2024-03-19 Evercore ISI Liisa Bayko Initiated $405 — +52.4% $265.68
2024-03-15 UBS Eliana Merle $337 $410 +73 +51.6% $270.37
2024-03-15 Jefferies Akash Tewari Initiated $400 — +47.9% $270.37
2024-03-15 H.C. Wainwright Ed Acre $225 $425 +200 +57.2% $270.37
2024-03-14 JMP Securities Jonathan Wolleben $390 $397 +7 +46.8% $270.37
2024-03-14 B.Riley Financial Mayank Mamtani Initiated $270 — -0.1% $270.37
2023-01-05 JMP Securities — $312 $390 +78 +42.1% $274.48
2022-12-21 UBS — Initiated $337 — +31.1% $257.12
2022-12-20 H.C. Wainwright — Initiated $225 — -10.5% $251.50
2022-12-20 Oppenheimer — Initiated $250 — +3.3% $242.00
2022-12-20 Goldman Sachs — $195 $375 +180 +59.7% $234.83
2022-12-20 JMP Securities — Initiated $312 — +32.9% $234.83
2022-12-20 Leerink Partners — Initiated $315 — +34.1% $234.83
2021-08-05 BMO Capital Matthew Luchini Initiated $111 — +22.0% $90.95
2021-05-19 Goldman Sachs Andrea Tan Initiated $195 — +50.3% $129.77
2021-05-05 Wells Fargo Derek Archila Initiated $130 — +2.6% $126.71

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 27, 2026
DCF
5
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. MDGL receives an overall rating of C. Strongest factors: DCF (5/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-07-31 C+ C
2026-07-30 C C+
2026-05-11 C+ C
2026-05-06 C C+
2026-03-25 C- C
2026-02-23 C C-
2026-02-20 C- C
2026-01-08 C C-
2026-01-03 C- C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 40 Grade D
Profitability
20
Balance Sheet
53
Earnings Quality
45
Growth
59
Value
32
Momentum
56
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. MDGL scores highest in Safety (100/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
11.55
Safe Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✓
Beneish M-Score
-0.17
Possible Manipulator
Ohlson O-Score
-5.83
Bankruptcy prob: 0.3%
Low Risk
Credit Rating
BBB+
Score: 61.2/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.61x
Accruals: -11.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. MDGL scores 11.55, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MDGL scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. MDGL's score of -0.17 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MDGL's implied 0.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MDGL receives an estimated rating of BBB+ (score: 61.2/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-34.16x
PEG
98.96x
P/S
7.92x
P/B
24.50x
P/FCF
-75.86x
P/OCF
—
EV/EBITDA
-51.90x
EV/Revenue
11.81x
EV/EBIT
-51.63x
EV/FCF
-73.48x
Earnings Yield
-2.08%
FCF Yield
-1.32%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. MDGL currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.107
EBT / EBIT
×
EBIT Margin
-0.229
EBIT / Rev
×
Asset Turnover
1.136
Rev / Assets
×
Equity Multiplier
1.853
Assets / Equity
=
ROE
-53.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MDGL's ROE of -53.3% is driven by Asset Turnover (1.136), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$440.33
Median 1Y
$416.16
5th Pctile
$136.37
95th Pctile
$1291.43
Ann. Volatility
73.6%
Analyst Target
$718.60
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Bill Sibold
President and Chief Executive Officer
 $889,583 $7,558,495 $12,214,250
Mardi Dier Financial
Vice President and Chief Financial Officer
 $464,679 $5,676,894 $8,751,912
Rebecca Taub, M.D.
Senior Scientific and Medical Advisor and Former President, Research & Development and Chief Medical Officer
 $596,209 $3,570,078 $5,967,206
Alex Howarth Financial
nior Vice President and Chief Financial Officer
 $294,547 $2,963,547 $5,242,872
Shannon Kelley Legal
tive Vice President and Chief Legal Counsel
 $441,655 $1,949,994 $4,673,764
Brian J. Lynch
Former Senior Vice President and General Counsel
 $380,109 $2,245,336 $4,250,806
Carole Huntsman Commercial
Vice President and Chief Commercial Officer
 $525,000 $2,245,336 $3,949,441

CEO Pay Ratio

14:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $12,214,250
Avg Employee Cost (SGA/emp): $889,428
Employees: 915

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
915
+73.3% YoY
Revenue / Employee
$1,047,435
Rev: $958,403,000
Profit / Employee
$-315,064
NI: $-288,284,000
SGA / Employee
$889,428
Avg labor cost proxy
R&D / Employee
$424,617
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -90.1% -1.1% -1.2% -1.4% -2.2% -1.5% -2.1% -3.5% -21.1% -1.2% -88.8% -1.1% -1.3% -80.3% -50.2% -36.3% -41.2% -42.5% -49.3% -53.3% -53.31%
ROA -73.4% -86.3% -92.7% -94.0% -1.2% -92.9% -1.1% -1.3% -1.8% -74.5% -62.8% -72.8% -79.1% -55.4% -37.7% -26.7% -23.7% -25.0% -27.8% -28.8% -28.77%
ROIC 3.0% 2.6% 2.7% 2.6% 2.3% 2.1% 2.6% 2.7% 2.9% 2.7% 4.0% 5.1% 4.2% 7.5% 26.5% -10.7% 1.8% 8.9% -3.4% -7.8% -7.79%
ROCE -1.0% -1.2% -1.7% -1.9% -4.6% -1.2% -1.3% -1.6% -2.4% -69.1% -44.4% -50.8% -56.2% -51.7% -45.5% -32.7% -28.0% -28.0% -31.8% -33.7% -33.73%
Gross Margin — — — — — — — — — — — 95.7% 96.5% 96.7% 96.7% 95.7% 93.7% 92.4% 91.4% 89.0% 89.02%
Operating Margin — — — — — — — — — — — -11.1% -1.9% -64.8% -57.8% -22.2% -39.7% -18.6% -29.8% -15.5% -15.46%
Net Margin — — — — — — — — — — — -10.4% -1.7% -57.5% -53.4% -19.9% -39.8% -18.2% -30.3% -15.9% -15.91%
EBITDA Margin — — — — — — — — — — — -10.1% -1.7% -53.8% -50.7% -18.2% -37.0% -15.5% -27.7% -13.6% -13.62%
FCF Margin — — — — — — — — — — — -31.1% -5.7% -2.6% -1.3% -59.8% -21.8% -19.8% -24.1% -16.1% -16.07%
OCF Margin — — — — — — — — — — — -30.7% -5.6% -2.5% -1.2% -59.6% -21.7% -19.8% -23.7% -15.4% -15.40%
ROE 3Y Avg snapshot only -54.04%
ROE 5Y Avg snapshot only -1.57%
ROA 3Y Avg snapshot only -33.43%
ROIC Economic snapshot only -30.13%
Cash ROA snapshot only -15.89%
Cash ROIC snapshot only -6.04%
CROIC snapshot only -6.30%
NOPAT Margin snapshot only -19.85%
Pretax Margin snapshot only -25.32%
R&D / Revenue snapshot only 38.17%
SGA / Revenue snapshot only 78.43%
SBC / Revenue snapshot only 7.45%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -5.62 -5.98 -6.80 -4.78 -4.06 -16.94 -14.00 -12.83 -7.77 -12.24 -12.02 -11.75 -8.90 -14.52 -18.69 -23.84 -35.67 -45.32 -49.11 -48.14 -34.161
P/S Ratio — — — — — — — — — — — 409.63 60.08 37.57 23.06 13.04 13.92 13.63 13.42 12.19 7.924
P/B Ratio 5.65 7.38 11.51 14.66 104.18 25.35 29.35 40.87 121.28 11.28 6.28 7.00 5.94 8.97 10.30 9.66 16.48 21.68 27.96 29.88 24.504
P/FCF -6.95 -7.86 -8.80 -6.08 -5.18 -22.23 -17.00 -15.26 -8.90 -14.04 -13.66 -13.15 -10.53 -14.65 -18.23 -21.79 -63.80 -68.75 -55.79 -75.86 -75.864
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -4.35 -4.87 -5.92 -4.17 -3.72 -16.14 -13.51 -12.56 -7.68 -11.25 -10.24 -10.22 -7.43 -13.24 -17.53 -22.67 -35.35 -47.02 -52.39 -51.90 -51.900
EV/Revenue — — — — — — — — — — — 345.43 48.63 33.09 20.78 11.73 12.89 12.97 13.00 11.81 11.806
EV/EBIT -4.34 -4.86 -5.91 -4.16 -3.71 -16.11 -13.49 -12.54 -7.67 -11.24 -10.23 -10.21 -7.42 -13.21 -17.47 -22.55 -35.15 -46.75 -52.11 -51.63 -51.632
EV/FCF -5.39 -6.39 -7.65 -5.28 -4.70 -20.86 -16.05 -14.55 -8.52 -12.45 -11.25 -11.09 -8.52 -12.90 -16.43 -19.61 -59.08 -65.44 -54.06 -73.48 -73.484
Earnings Yield -17.8% -16.7% -14.7% -20.9% -24.6% -5.9% -7.1% -7.8% -12.9% -8.2% -8.3% -8.5% -11.2% -6.9% -5.4% -4.2% -2.8% -2.2% -2.0% -2.1% -2.08%
FCF Yield -14.4% -12.7% -11.4% -16.4% -19.3% -4.5% -5.9% -6.6% -11.2% -7.1% -7.3% -7.6% -9.5% -6.8% -5.5% -4.6% -1.6% -1.5% -1.8% -1.3% -1.32%
PEG Ratio snapshot only 98.961
Price/Tangible Book snapshot only 30.297
EV/Gross Profit snapshot only 12.906
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 4.37 3.54 2.89 2.55 1.59 3.12 3.37 3.02 2.36 5.38 9.39 8.72 5.98 6.10 5.91 5.11 3.44 4.01 3.50 3.20 3.205
Quick Ratio 4.37 3.54 2.89 2.55 1.59 3.12 3.37 3.02 2.36 5.38 9.39 8.67 5.93 5.90 5.58 4.78 3.26 3.77 3.16 2.94 2.939
Debt/Equity 0.00 0.00 0.00 0.60 4.67 0.25 0.56 0.96 5.24 0.29 0.14 0.14 0.15 0.16 0.17 0.18 0.55 0.59 0.64 0.66 0.664
Net Debt/Equity -1.27 -1.37 -1.50 -1.94 -9.69 -1.56 -1.63 -1.92 -5.20 -1.28 -1.11 -1.10 -1.13 -1.07 -1.02 -0.97 -1.22 -1.04 -0.87 -0.94 -0.938
Debt/Assets 0.00 0.00 0.00 0.23 0.31 0.14 0.25 0.33 0.49 0.18 0.11 0.11 0.11 0.11 0.12 0.12 0.25 0.28 0.28 0.28 0.279
Debt/EBITDA -0.00 -0.00 -0.00 -0.20 -0.18 -0.17 -0.27 -0.31 -0.35 -0.33 -0.27 -0.24 -0.24 -0.27 -0.32 -0.46 -1.28 -1.34 -1.24 -1.19 -1.191
Net Debt/EBITDA 1.26 1.11 0.89 0.64 0.38 1.06 0.80 0.62 0.34 1.43 2.19 1.90 1.75 1.79 1.92 2.52 2.83 2.38 1.67 1.68 1.681
Interest Coverage — — — -327.14 -119.09 -73.51 -48.96 -38.16 -32.32 -28.39 -30.26 -33.10 -33.25 -30.75 -26.71 -19.52 -15.51 -11.92 -10.53 -9.32 -9.318
Equity Multiplier 1.30 1.39 1.53 2.59 14.87 1.84 2.21 2.92 10.70 1.58 1.27 1.28 1.38 1.38 1.40 1.46 2.18 2.09 2.26 2.38 2.377
Cash Ratio snapshot only 2.241
Debt Service Coverage snapshot only -9.270
Cash to Debt snapshot only 2.412
FCF to Debt snapshot only -0.593
Defensive Interval snapshot only 251.4 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.12 0.21 0.31 0.49 0.61 0.83 1.02 1.14 1.136
Inventory Turnover — — — — — — — — — — 0.33 0.22 0.67 0.37 0.38 0.54 0.90 1.03 0.94 1.34 1.344
Receivables Turnover — — — — — — — — — — — 4.24 5.04 6.69 10.33 11.97 10.30 10.18 9.10 9.46 9.457
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.06 0.09 0.17 0.34 0.82 0.77 1.21 1.53 3.02 3.019
DSO — — — — — — — — — — — 86 72 55 35 30 35 36 40 39 38.6 days
DIO — — — — — — — — — 0 1098 1659 543 997 953 672 405 354 389 272 271.7 days
DPO — — — — — — — — — 66666 43255 6223 3893 2098 1080 447 472 301 239 121 120.9 days
Cash Conversion Cycle — — — — — — — — — — — -4478 -3278 -1046 -92 255 -31 89 190 189 189.4 days
Fixed Asset Turnover snapshot only 74.778
Operating Cycle snapshot only 310.3 days
Cash Velocity snapshot only 1.531
Capital Intensity snapshot only 0.969
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — — — — — — — — — — — — — 34.2% 8.6% 4.3% 2.6% 1.5% 1.49%
Net Income -38.4% -19.6% -12.9% -10.6% -15.9% -22.1% -27.5% -28.9% -26.8% -26.5% -41.2% -54.8% -49.3% -24.7% 11.9% 44.8% 44.3% 38.1% 21.0% -15.3% -15.32%
EPS -28.5% -8.4% -4.5% -7.2% -12.8% -21.0% -19.9% -20.4% -17.3% -10.3% -28.4% -32.4% -26.9% -12.4% 20.2% 46.8% 46.1% 39.5% 39.9% 12.1% 12.13%
FCF -65.5% -16.6% -11.8% -4.2% -12.5% -22.2% -36.0% -37.7% -41.3% -44.7% -50.9% -64.5% -44.5% -41.9% -2.6% 32.3% 63.1% 58.9% 32.1% 33.1% 33.11%
EBITDA -34.1% -17.3% -11.4% -9.6% -14.5% -20.3% -24.9% -26.0% -24.0% -23.9% -39.5% -54.2% -49.4% -24.9% 12.4% 46.1% 46.3% 41.2% 25.3% -9.5% -9.50%
Op. Income -34.1% -17.3% -11.5% -9.7% -14.9% -21.1% -27.2% -29.3% -27.8% -29.6% -44.5% -60.5% -57.2% -30.8% 6.4% 41.6% 43.9% 39.7% 26.3% -4.1% -4.13%
OCF Growth snapshot only 35.68%
Asset Growth snapshot only 22.58%
Equity Growth snapshot only -24.75%
Debt Growth snapshot only 1.81%
Shares Change snapshot only 31.24%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — — — — — — — — — — —
Revenue 5Y — — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y -14.6% -17.4% -22.6% -22.8% -29.7% -6.4% -6.9% -8.0% -11.2% 30.7% 51.7% 49.7% 52.2% 56.2% 64.8% 67.4% 1.0% 51.5% 54.6% 60.2% 60.25%
Assets 5Y 49.0% 46.0% 40.7% 26.0% 20.4% 13.5% 12.6% -9.3% -13.4% 5.7% 17.7% 18.5% 18.7% 18.7% 19.4% 21.2% 32.0% 34.4% 31.7% 30.6% 30.57%
Equity 3Y -21.4% -25.6% -32.2% -43.2% -71.1% -22.0% -27.0% -32.9% -57.5% 19.1% 48.4% 46.9% 49.0% 56.7% 69.6% 1.0% 2.9% 45.1% 53.5% 71.7% 71.68%
Book Value 3Y -23.5% -28.2% -34.6% -45.2% -72.0% -24.9% -30.9% -36.6% -60.0% 9.8% 37.3% 34.8% 36.3% 44.1% 55.7% 85.8% 2.5% 32.9% 31.4% 47.0% 47.04%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.41 0.41 0.41 0.41 0.43 0.48 0.53 0.58 0.64 0.639
Earnings Stability 0.80 0.84 0.87 0.90 0.94 0.95 0.96 0.98 0.98 0.98 0.97 0.95 0.95 0.98 0.89 0.49 0.46 0.44 0.41 0.15 0.152
Margin Stability — — — — — — — — — — — — — — — — — — — 0.97 0.974
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.85 0.92 0.95 0.96 0.94 0.91 0.89 0.88 0.89 0.89 0.84 0.50 0.80 0.90 0.95 0.82 0.82 0.85 0.92 0.94 0.939
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend -0.63 -0.71 -1.14 -2.44 -24.88 -0.46 -0.83 -1.23 -2.27 0.44 1.37 2.53 19.98 0.59 0.76 1.49 7.68 0.29 -0.03 -0.12 -0.120
Gross Margin Trend — — — — — — — — — — — — — — — — — — — -0.04 -0.040
FCF Margin Trend — — — — — — — — — — — — — — — — — — — 15.71 15.708
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.81 0.76 0.77 0.79 0.78 0.76 0.82 0.84 0.87 0.87 0.88 0.88 0.83 0.98 1.01 1.09 0.56 0.66 0.87 0.61 0.608
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.02 1.02 1.01 1.02 1.00 1.01 1.00 1.02 1.04 1.043
FCF/Net Income snapshot only 0.635
CapEx/Revenue — — — — — — — — — — — 46.9% 9.5% 3.6% 1.9% 0.2% 0.1% 0.0% 0.4% 0.7% 0.67%
CapEx/Depreciation snapshot only 5.649
Accruals Ratio -0.14 -0.21 -0.21 -0.20 -0.26 -0.22 -0.20 -0.20 -0.22 -0.10 -0.08 -0.09 -0.13 -0.01 0.00 0.02 -0.11 -0.09 -0.04 -0.11 -0.113
Sloan Accruals snapshot only 0.015
Cash Flow Adequacy snapshot only -23.073
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -11.4% -11.8% -6.2% -3.3% -1.7% -5.1% -5.8% -6.6% -10.4% -5.7% -10.7% -10.6% -13.7% -5.9% -1.3% -0.0% -0.2% -0.2% -0.1% -0.2% -0.21%
Total Shareholder Return -11.4% -11.8% -6.2% -3.3% -1.7% -5.1% -5.8% -6.6% -10.4% -5.7% -10.7% -10.6% -13.7% -5.9% -1.3% -0.0% -0.2% -0.2% -0.1% -0.2% -0.21%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.01 1.01 1.02 1.03 1.03 1.04 1.03 1.03 1.03 1.03 1.04 1.05 1.06 1.08 1.09 1.11 1.107
EBIT Margin — — — — — — — — — — — -33.85 -6.56 -2.50 -1.19 -0.52 -0.37 -0.28 -0.25 -0.23 -0.229
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.12 0.21 0.31 0.49 0.61 0.83 1.02 1.14 1.136
Equity Multiplier 1.23 1.28 1.31 1.54 1.89 1.62 1.88 2.77 12.05 1.66 1.41 1.46 1.64 1.45 1.33 1.36 1.74 1.70 1.77 1.85 1.853
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-14.21 $-14.16 $-14.43 $-14.96 $-16.02 $-17.13 $-17.30 $-18.01 $-18.80 $-18.91 $-22.21 $-23.85 $-23.85 $-21.25 $-17.73 $-12.69 $-12.86 $-12.85 $-10.66 $-11.15 $-11.15
Book Value/Share $14.12 $11.49 $8.52 $4.88 $0.62 $11.45 $8.25 $5.65 $1.20 $20.51 $42.53 $40.05 $35.74 $34.40 $32.17 $31.34 $27.83 $26.86 $18.72 $17.97 $17.97
Tangible Book/Share $14.12 $11.49 $8.52 $4.88 $0.62 $11.45 $8.25 $5.65 $1.20 $20.51 $42.28 $39.82 $35.52 $34.18 $31.96 $31.14 $27.50 $26.54 $18.47 $17.72 $17.72
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.68 $3.53 $8.21 $14.37 $23.22 $32.94 $42.72 $39.01 $44.05 $44.05
FCF/Share $-11.47 $-10.78 $-11.15 $-11.76 $-12.55 $-13.06 $-14.25 $-15.13 $-16.41 $-16.48 $-19.55 $-21.30 $-20.16 $-21.07 $-18.17 $-13.89 $-7.19 $-8.47 $-9.38 $-7.08 $-7.08
OCF/Share $-11.47 $-10.77 $-11.13 $-11.75 $-12.54 $-13.04 $-14.24 $-15.13 $-16.39 $-16.41 $-19.46 $-20.98 $-19.82 $-20.77 $-17.89 $-13.84 $-7.14 $-8.45 $-9.23 $-6.78 $-6.78
Cash/Share $17.98 $15.83 $12.86 $12.38 $8.96 $20.81 $18.12 $16.30 $12.58 $32.09 $52.95 $49.42 $45.92 $42.24 $38.16 $35.89 $49.36 $43.84 $28.17 $28.78 $28.78
EBITDA/Share $-14.24 $-14.17 $-14.41 $-14.89 $-15.86 $-16.88 $-16.93 $-17.52 $-18.21 $-18.24 $-21.47 $-23.12 $-23.11 $-20.53 $-17.03 $-12.01 $-12.02 $-11.79 $-9.68 $-10.02 $-10.02
Debt/Share $0.05 $0.05 $0.04 $2.91 $2.91 $2.89 $4.65 $5.44 $6.31 $5.93 $5.89 $5.52 $5.48 $5.45 $5.42 $5.58 $15.41 $15.80 $11.96 $11.93 $11.93
Net Debt/Share $-17.92 $-15.79 $-12.82 $-9.47 $-6.04 $-17.92 $-13.46 $-10.85 $-6.27 $-26.16 $-47.06 $-43.91 $-40.44 $-36.79 $-32.74 $-30.31 $-33.95 $-28.05 $-16.21 $-16.85 $-16.85
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 11.550
Altman Z-Prime snapshot only 19.682
Piotroski F-Score 1 1 1 1 1 1 2 2 2 3 4 5 5 5 2 3 3 3 3 2 2
Beneish M-Score — — — — — — — — — — — — — — — 9.64 0.40 -0.87 0.73 -0.17 -0.169
Ohlson O-Score snapshot only -5.832
ROIC (Greenblatt) snapshot only -34.86%
Net-Net WC snapshot only $16.41
EVA snapshot only $-258138050.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB+
Credit Score 72.96 74.15 74.33 28.48 20.10 64.03 61.78 61.98 21.68 64.07 65.06 65.43 65.07 65.32 65.56 65.09 61.79 61.47 61.44 61.25 61.245
Credit Grade snapshot only 8
Credit Trend snapshot only -3.850
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 57
Sector Credit Rank snapshot only 53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms